*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Brivaracetam is a potent antiepileptic drug derived from levetiracetam, synthesized via <strong>chiral resolution</strong> or asymmetric synthesis. Its molecular formula is <strong>C12H18N2O2</strong> with CAS No. <strong>264095-07-2</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Epilepsy Treatment:</strong> Adjunctive therapy for partial-onset seizures in adults.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> API production for generic and branded seizure medications.</li>
<li><strong>Research & Development:</strong> Neurological studies focusing on synaptic vesicle protein 2A binding.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly adhere to dosage limits to avoid CNS depression. Store in <strong>cool, dry conditions</strong> below 25°C protected from light. Handle with appropriate PPE to prevent skin contact and inhalation of dust particles.</p>